Effect of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on ventricular repolarization electrocardiographic parameters in type 2 diabetes patients: DAPA - ECG study

Authors

Institutions

Publication Details

Journal
Frontiers in Clinical Diabetes and Healthcare
Published
2025-03-31
DOI
https://doi.org/10.3389/fcdhc.2025.1537005
Citations
1
Primary Topic
Cardiac electrophysiology and arrhythmias
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on ventricular repolarization electrocardiographic parameters in type 2 diabetes patients: DAPA - ECG study

Gabriel M. Fonseca, Dalmo Antônio Ribeiro Moreira, Rodrigo Noronha Campos
1 citations
Frontiers in Clinical Diabetes and Healthcare
Cardiac electrophysiology and arrhythmias
1.39
article

Effect of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on ventricular repolarization electrocardiographic parameters in type 2 diabetes patients: DAPA - ECG study

Gabriel M. Fonseca, Dalmo Antônio Ribeiro Moreira, Rodrigo Noronha Campos
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in Clinical Diabetes and HealthcareVol. 6
Beneficência Portuguesa de São Paulo (BR), Instituto Dante Pazzanese de Cardiologia (BR), Hospital São Paulo (BR)
Openalex Percentile: Top 21%
Cardiac electrophysiology and arrhythmias
1.39
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.